Vascular Clinical Trials
CLI & AMI

Blood and Bone Marrow
Bioprocessing

Bone Marrow Transplant
Innovation

News Updates

CESCA THERAPEUTICS ANNOUNCES COMPLIANCE WITH NASDAQ STOCK MARKET UNDER...

June 30, 2015

RANCHO CORDOVA, Calif – June 25, 2015 – Cesca Therapeutics, Inc. (NASDAQ:KOOL), an autologous ce...

Read More >>

CESCA THERAPEUTICS REPORTS THIRD QUARTER FISCAL 2015 RESULTS

June 24, 2015

Company receives US FDA approval for its IDE Submission to the FDA for a Phase III Pivotal Clinical ...

Read More >>

Video Library